A recent study demonstrated that KDM6A is a co-activator of the oncogenic transcription factor TAL1 and is essential for disease progression of TAL1-positive T-cell acute lymphoblastic leukemia (T-ALL) [138]. Here, TAL1 is linked to T-cell acute lymphoblastic leukemia.